| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/13/2006 | US20060153836 Using monoclonal antibody specific for kidney injury-molecule-1 (KIM-1) to diagnose, prevent and treat cell proliferative and kidney disorders; immunotherapeutics |
| 07/13/2006 | US20060153833 Anti hepatitis C virus antibody and uses thereof |
| 07/13/2006 | US20060153827 Chimeric protein |
| 07/13/2006 | US20060153826 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof |
| 07/13/2006 | US20060153825 Use of protein histidine phosphatase |
| 07/13/2006 | US20060153821 Induction of tumor and viral immunity using antigen presenting cell co-culture products and fusion products |
| 07/13/2006 | US20060153820 Materials and methods relating to the production and maintenance of cell lines |
| 07/13/2006 | US20060153811 Use of viruses and virus-resistant microorganisms for controlling microorganism populations |
| 07/13/2006 | US20060153810 Process for preparing retrovirus vector for gene therapy |
| 07/13/2006 | US20060153809 Recombinant trail vectors and uses thereof |
| 07/13/2006 | US20060153805 Viral vectors and the use of the same for gene therapy |
| 07/13/2006 | US20060153804 Nucleic acid coated particles |
| 07/13/2006 | US20060153802 Mammalian chemokine reagents |
| 07/13/2006 | DE102004063494A1 Antikörper Antibody |
| 07/13/2006 | DE102004062196A1 New polynucleotide encoding insect phosphatidylinositol-4-phosphate-5 -kinase, useful as a target for identification of insecticides, also new protein, vector and recombinant cells |
| 07/13/2006 | DE102004062195A1 New polynucleotide encoding insect slingshot-protein phosphatase, useful as a target for identification of insecticides, also new protein, vector and recombinant cells |
| 07/13/2006 | DE102004061886A1 New polynucleotide encoding insect diacylglycerol kinase, useful as a target for identification of insecticides, also new protein, vector and recombinant cells |
| 07/13/2006 | DE102004061877A1 New polynucleotide encoding insect 5-aminolevulinate synthase, useful as a target for identification of insecticides, also new protein, vector and recombinant cells |
| 07/13/2006 | DE102004061849A1 New polynucleotide encoding insect acyl-CoA-dehydrogenase, useful as a target for identification of insecticides, also new protein, vector and recombinant cells |
| 07/13/2006 | DE102004061848A1 New polynucleotide encoding insect BUB-1 kinase domain, useful as a target for identification of insecticides, also new protein, vector and recombinant cells |
| 07/13/2006 | DE102004061846A1 Mehrfachpromotoren Multiple promoters |
| 07/13/2006 | DE10060133B4 Wirts-Vektor-System für die heterologe Genexpression in der Hefe Debaryomyces The host-vector system for heterologous gene expression in the yeast Debaryomyces |
| 07/13/2006 | DE10057014B4 Verfahren zur Herstellung von zielzellspezifischen Arzneimitteln Process for the preparation of target cell-specific drugs |
| 07/13/2006 | CA2595080A1 Transformed plant expressing a mutansucrase and synthesizing a modified starch |
| 07/13/2006 | CA2594356A1 Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regions |
| 07/13/2006 | CA2594334A1 Rnai modulation of rsv and therapeutic uses thereof |
| 07/13/2006 | CA2594276A1 Neutralizing epitope-based growth enhancing vaccine |
| 07/13/2006 | CA2594040A1 Rna interference that blocks expression of pro-apoptotic proteins potentiates immunity induced by dna and transfected dendritic cell vaccines |
| 07/13/2006 | CA2594023A1 Igf-i fusion polypeptides and therapeutic uses thereof |
| 07/13/2006 | CA2593509A1 Rnai agents for maintenance of stem cells |
| 07/13/2006 | CA2593417A1 Method of mutagenesis |
| 07/13/2006 | CA2593238A1 Method to trigger rna interference |
| 07/13/2006 | CA2593212A1 Cripto binding molecules |
| 07/13/2006 | CA2593151A1 Ribosome display or mrna display method with selection for increased stability of the protein |
| 07/13/2006 | CA2593128A1 Functional viral vectors for the overexpression or extinction of particular genes in plants, and applications thereof |
| 07/13/2006 | CA2593080A1 Acid fungal proteases |
| 07/13/2006 | CA2593018A1 Hot start polymerase reaction using a thermolabile blocker |
| 07/13/2006 | CA2592704A1 Nucleotide sequences encoding ramosa3 and sister of ramosa3 and methods of use for same |
| 07/13/2006 | CA2592614A1 Antibodies against il-13 receptor alpha 1 and uses thereof |
| 07/13/2006 | CA2591230A1 Nucleic acid molecules encoding fatty acid desaturase genes from plants and methods of use |
| 07/13/2006 | CA2589060A1 Hemopexin-like structure as polypeptide-scaffold |
| 07/13/2006 | CA2588644A1 Inhibition of li expression in mammalian cells |
| 07/13/2006 | CA2588026A1 Methods and compositions for rna interference |
| 07/13/2006 | CA2587320A1 Transplastomic plants free of the selectable marker gene |
| 07/13/2006 | CA2571560A1 Avipox recombinants expressing foot and mouth disease virus genes |
| 07/13/2006 | CA2567599A1 Kits and processes for removing contaminants from nucleic acids in environmental and biological samples |
| 07/13/2006 | CA2566507A1 Prophylactic and therapeutic uses of fgf-20 in radiation protection |
| 07/12/2006 | EP1679515A1 Bio-assay substrate having a power supply wire configuration |
| 07/12/2006 | EP1679383A2 Method and device for purifying nucleid acids |
| 07/12/2006 | EP1679377A1 Feline immunodeficiency virus vaccine |
| 07/12/2006 | EP1679376A2 Recombinant adenovirus comprising a chimeric penton base protein |
| 07/12/2006 | EP1679375A1 Methods and compositions for cancer therapies using genes encoding interferon-beta |
| 07/12/2006 | EP1679374A1 Transformed plant expressing a mutansucrase and synthesizing a modified starch |
| 07/12/2006 | EP1679373A2 Lipase and use of same for improving doughs and baked products |
| 07/12/2006 | EP1679371A1 Method of evaluating cancerization degree |
| 07/12/2006 | EP1679370A1 Method of evaluating cancerization degree |
| 07/12/2006 | EP1679369A2 Method of extending single-stranded nucleic acid, single-stranded nucleic acid extending apparatus and dna chip |
| 07/12/2006 | EP1679320A1 Derivatives of breast cancer antigen her-2 for therapeutical use |
| 07/12/2006 | EP1679080A2 Prevention and treatment of amyloidogenic disease |
| 07/12/2006 | EP1678316A2 Campylobacter polypeptides and methods of use |
| 07/12/2006 | EP1678314A1 Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy |
| 07/12/2006 | EP1678312A1 Retroviral vectors for delivery of interfering rna |
| 07/12/2006 | EP1678311A2 Retroviral and lentiviral vectors |
| 07/12/2006 | EP1678310A1 Axmi-010, a delta-endotoxin gene and methods for its use |
| 07/12/2006 | EP1678309A1 A thermophilic host-vector system |
| 07/12/2006 | EP1678308A1 Expression vector for secreting antibody fragment using e. coli signal sequence and method for mass-producing antibody fragment |
| 07/12/2006 | EP1678307A1 Methods and compositions for defining gene function |
| 07/12/2006 | EP1678306A1 Method for inducing a specific rnai activity in cells and nucleic acids for carrying out said method |
| 07/12/2006 | EP1678304A1 Cellular model of tauopathies for lead identification and drug discovery |
| 07/12/2006 | EP1678303A2 C-class oligonucleotide analogs with enhanced immunostimulatory potency |
| 07/12/2006 | EP1678302A1 Antisense oligonucleotides for prevention of metastasis formation of cancer cells |
| 07/12/2006 | EP1678301A1 Inducible bacterial expression system utilising sspa promoter from salmonella |
| 07/12/2006 | EP1678300A1 Method for the production of full-length dnac by ligaturation of an adapter with a cohesive extremity |
| 07/12/2006 | EP1678299A2 Method from the selection of biomolecules from biomolecule variant libraries |
| 07/12/2006 | EP1678298A2 Expression of dominant negative transmembrane receptors in the milk of transgenic animals |
| 07/12/2006 | EP1678293A2 Compositions of stabilized dna for coating microprojections |
| 07/12/2006 | EP1678292A2 Improved mva vaccines |
| 07/12/2006 | EP1678291A2 Isolated nucleotide sequences responsible for the tomato high pigment-1 mutant phenotypes (hp-1 and hp-1w) and uses thereof |
| 07/12/2006 | EP1678206A2 Oligomeric complexe formation of recombinant multi subunit chimeric polypeptides |
| 07/12/2006 | EP1678205A1 Clq RELATED PROTEIN |
| 07/12/2006 | EP1678204A1 Novel phosphate-binding protein, pharmaceutical compositions containing same and use thereof |
| 07/12/2006 | EP1678203A2 Multiepitope polypeptides for cancer immunotherapy |
| 07/12/2006 | EP1678202A1 Hcv ns3-ns4a protease resistance mutants |
| 07/12/2006 | EP1678195A2 Methods and compositions for diagnosis and treatment of b cell chronic lymphocytic leukemia |
| 07/12/2006 | EP1678193A1 Hepatocellular carcinoma specific promoter and uses thereof |
| 07/12/2006 | EP1678131A2 Methods for making simvastatin and intermediates |
| 07/12/2006 | EP1677834A2 Defined dose therapeutic phage |
| 07/12/2006 | EP1677833A2 In vivo gene therapy of parkinson's disease |
| 07/12/2006 | EP1677832A1 Lentivirus vector-based approaches for generating an immune response to hiv humans |
| 07/12/2006 | EP1677822A2 4'-thionucleosides and oligomeric compounds |
| 07/12/2006 | EP1677820A1 Colorectal cancer antigen |
| 07/12/2006 | EP1677815A1 Selective inhibition of nf-kappab activation by peptides designed to disrupt nemo oligomerization. |
| 07/12/2006 | EP1677739A2 Methods of identifying agents that inhibit the growth of cancer cells |
| 07/12/2006 | EP1677703A2 Chemical treatment for removing cellular and nuclear material from naturally occurring extracellular matrix-based biomaterials |
| 07/12/2006 | EP1677665A2 Determination of ions using ion-sensitive enzymes |
| 07/12/2006 | EP1590663A4 Immunocompromised rodents as dual color tumor models |
| 07/12/2006 | EP1534749A4 Variant integrin polypeptides and uses thereof |
| 07/12/2006 | EP1506225B1 Novel peptide compositions and the use thereof, in particular, in the preparation of active pharmaceutical compositions against the hepatitis c virus |
| 07/12/2006 | EP1504046B1 Tri-block polymers for nanosphere-based drug or gene delivery |
| 07/12/2006 | EP1499279A4 MOLECULES THAT MODULATE GaQ ACTIVITY AND METHODS OF TREATING URINARY INCONTINENCE |